As gene therapy for Duchenne muscular dystrophy faces scrutiny after tragic deaths, families like the Revells navigate the uncertain waters of hope and risk, questioning the future of their loved ones.
Former President Biden's prostate cancer diagnosis has reignited the debate over the effectiveness of PSA testing, a screening tool fraught with risks and benefits. Experts weigh in on the complexities of detecting aggressive cancers versus over-treatment of indolent cases.
